Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models.

Raffaella Sordella, Daphne W Bell, Daniel A Haber, Jeffrey Settleman, Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways Science. ,vol. 305, pp. 1163- 1167 ,(2004) , 10.1126/SCIENCE.1101637

Judith S. Sebolt-Leopold, Roman Herrera, Targeting the mitogen-activated protein kinase cascade to treat cancer Nature Reviews Cancer. ,vol. 4, pp. 937- 947 ,(2004) , 10.1038/NRC1503

Kian-Huat Lim, Christopher M. Counter, Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance Cancer Cell. ,vol. 8, pp. 381- 392 ,(2005) , 10.1016/J.CCR.2005.10.014

Hongbin Ji, Danan Li, Liang Chen, Takeshi Shimamura, Susumu Kobayashi, Kate McNamara, Umar Mahmood, Albert Mitchell, Yangping Sun, Ruqayyah Al-Hashem, Lucian R. Chirieac, Robert Padera, Roderick T. Bronson, William Kim, Pasi A. Jänne, Geoffrey I. Shapiro, Daniel Tenen, Bruce E. Johnson, Ralph Weissleder, Norman E. Sharpless, Kwok-Kin Wong, The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies Cancer Cell. ,vol. 9, pp. 485- 495 ,(2006) , 10.1016/J.CCR.2006.04.022

David B. Solit, Levi A. Garraway, Christine A. Pratilas, Ayana Sawai, Gad Getz, Andrea Basso, Qing Ye, Jose M. Lobo, Yuhong She, Iman Osman, Todd R. Golub, Judith Sebolt-Leopold, William R. Sellers, Neal Rosen, BRAF mutation predicts sensitivity to MEK inhibition Nature. ,vol. 439, pp. 358- 362 ,(2006) , 10.1038/NATURE04304

Galen H Fisher, Shari L Wellen, David Klimstra, Joi M Lenczowski, Jay W Tichelaar, Martin J Lizak, Jeffrey A Whitsett, Alan Koretsky, Harold E Varmus, Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes Genes & Development. ,vol. 15, pp. 3249- 3262 ,(2001) , 10.1101/GAD.947701

Ulf R. Rapp, Thomas Papadopoulos, Eugen Kerkhoff, Renate Siefken, Annette O. Walter, Lev M. Fedorov, Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein. Cell Growth & Differentiation. ,vol. 11, pp. 185- 190 ,(2000)

Marie Wislez, M. Loreto Spencer, Julie G. Izzo, Denise M. Juroske, Kamna Balhara, Dianna D. Cody, Roger E. Price, Walter N. Hittelman, Ignacio I. Wistuba, Jonathan M. Kurie, Inhibition of Mammalian Target of Rapamycin Reverses Alveolar Epithelial Neoplasia Induced by Oncogenic K-ras Cancer Research. ,vol. 65, pp. 3226- 3235 ,(2005) , 10.1158/0008-5472.CAN-04-4420

Katerina Politi, Maureen F Zakowski, Pang-Dian Fan, Emily A Schonfeld, William Pao, Harold E Varmus, Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors Genes & Development. ,vol. 20, pp. 1496- 1510 ,(2006) , 10.1101/GAD.1417406

John Rinehart, Alex A. Adjei, Patricia M. LoRusso, David Waterhouse, J. Randolph Hecht, Ronald B. Natale, Oday Hamid, Mary Varterasian, Peggy Asbury, Eric P. Kaldjian, Stephen Gulyas, David Y. Mitchell, Roman Herrera, Judith S. Sebolt-Leopold, Mark B. Meyer, Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer Journal of Clinical Oncology. ,vol. 22, pp. 4456- 4462 ,(2004) , 10.1200/JCO.2004.01.185